课题基金 / 基金详情

DEVELOPMENT OF MODULAR NUCLEIC ACID SURROGATES

DEVELOPMENT OF MODULAR NUCLEIC ACID SURROGATES
模块化核酸替代物的开发
批准号:
2406564
负责人:
PHILIP P GARNER
金额:
$15.75万
依托单位国家:
美国
项目类别:
财政年份:
1997
资助国家:
美国
项目状态:
已结题
起止时间:
1997-08-01 至 2000-07-30

项目摘要

项目成果

PHILIP P GARNER的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The overall aim of this project is to develop a new class of nucleic acid surrogates capable of sequence specific binding to single stranded DNA & RNA as well as double-stranded DNA targets. The repeating structural units for the proposed modules include peptide- and peptidomimetic-based nucleic acid surrogates. Once synthesized (in suitably protected form), the nucleobase-containing modules will be linked together via peptide and/or amide bonds to give the required oligomeric structures having defined nucleobase sequences. For each structural type, the research plan will entail: (1) computational evaluation of each surrogate to see if it can accommodate hybridization to complementary nucleic acid targets, (2) molecular synthesis and characterization of oligomeric structures having defined sequences of nucleobases, and finally (3) physicochemical evaluation of the hybridization potential of the resulting surrogates with specific nucleic acid target sequences. Iteration of this rational approach (design, synthesis, & evaluation) is expected to lead to nucleic acid surrogates that bind specifically to their nucleic acid target sequences. Alternatively, a combinatorial synthesis/affinity chromatography approach will be used to produce mixed residue surrogates capable of sequence specific triplex formation and molecular recognition of unusual nucleic acid tertiary structures (loops, junctions, etc.). If successful, this research project could lead to more effective antisense/antigene probes and/or drug carriers for use as genetically-based medicines in the treatment of viral infections and cancer.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
DEVELOPMENT OF MODULAR NUCLEIC ACID SURROGATES
  • 批准号:
    6031065
  • 项目类别:
  • 资助金额:
    $2.41万
  • 财政年份:
    1997
  • 负责人:
    PHILIP P GARNER
  • 依托单位:
DEVELOPMENT OF MODULAR NUCLEIC ACID SURROGATES
  • 批准号:
    2750120
  • 项目类别:
  • 资助金额:
    $12.79万
  • 财政年份:
    1997
  • 负责人:
    PHILIP P GARNER
  • 依托单位:
DEVELOPMENT OF MODULAR NUCLEIC ACID SURROGATES
  • 批准号:
    6019206
  • 项目类别:
  • 资助金额:
    $13.2万
  • 财政年份:
    1997
  • 负责人:
    PHILIP P GARNER
  • 依托单位:
ASYMMETRIC SYNTHESIS OF BIOACTIVE ALKALOIDS
  • 批准号:
    3295499
  • 项目类别:
  • 资助金额:
    $14.34万
  • 财政年份:
    1992
  • 负责人:
    PHILIP P GARNER
  • 依托单位:
国内基金
海外基金
基于合成生物标志物的超多重RNA数字化检测平台用于肿瘤精准诊断和分期评估
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    程子译
  • 依托单位:
RNA m6A修饰通过调控FDX1介导的铜死亡参与补阳还五汤抗脑缺血再灌注损伤作用机制的研究
  • 批准号:
    2026JJ81091
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    刘亮
  • 依托单位:
免标记CRISPR-RNA适配体与门逻辑分子诊断新方法研究
  • 批准号:
    2026JJ50010
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    应站明
  • 依托单位:
RNA 结合蛋白HuR与VEGF-D联合调控舌鳞癌侵袭及转移机制的研究
  • 批准号:
    2026JJ80684
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    龚攀
  • 依托单位: